Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 977

2.

Hexapeptide-conjugated calcitonin for targeted therapy of osteoporosis.

Liu Y, Yu P, Peng X, Huang Q, Ding M, Chen Y, Jin R, Xie J, Zhao C, Li J.

J Control Release. 2019 Jun 28;304:39-50. doi: 10.1016/j.jconrel.2019.04.042. Epub 2019 May 2.

PMID:
31054990
3.

[Effect of salmon calcitonin on postoperative humeral head replacement in elderly patients].

Dai HF, Liu F, Li J, Wang ZH, Lyu YM, Xu C.

Zhongguo Gu Shang. 2019 Feb 25;32(2):136-140. doi: 10.3969/j.issn.1003-0034.2019.02.008. Chinese.

PMID:
30884929
4.

Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model.

Katri A, Dąbrowska A, Löfvall H, Ding M, Karsdal MA, Andreassen KV, Thudium CS, Henriksen K.

Arthritis Res Ther. 2019 Feb 22;21(1):68. doi: 10.1186/s13075-019-1819-9.

5.

Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.

Liu L, Yang H, Lou Y, Wu JY, Miao J, Lu XY, Gao JQ.

Int J Pharm. 2019 Feb 25;557:170-177. doi: 10.1016/j.ijpharm.2018.12.053. Epub 2018 Dec 28.

PMID:
30597264
6.

An intestinal paracellular pathway biased toward positively-charged macromolecules.

Almansour K, Taverner A, Turner JR, Eggleston IM, Mrsny RJ.

J Control Release. 2018 Oct 28;288:111-125. doi: 10.1016/j.jconrel.2018.09.003. Epub 2018 Sep 6.

PMID:
30194947
7.

Inhibition of the fibrillation of highly amyloidogenic human calcitonin by cucurbit[7]uril with improved bioactivity.

Shang H, Zhou A, Jiang J, Liu Y, Xie J, Li S, Chen Y, Zhu X, Tan H, Li J.

Acta Biomater. 2018 Sep 15;78:178-188. doi: 10.1016/j.actbio.2018.07.045. Epub 2018 Aug 2.

PMID:
30076991
8.

Intra-articular delivery of a nanocomplex comprising salmon calcitonin, hyaluronic acid, and chitosan using an equine model of joint inflammation.

Sladek S, Kearney C, Crean D, Brama PAJ, Tajber L, Fawcett K, Labberte MC, Leggett B, Brayden DJ.

Drug Deliv Transl Res. 2018 Oct;8(5):1421-1435. doi: 10.1007/s13346-018-0557-x.

PMID:
29947020
9.

Treatment of extreme hypercalcaemia: the role of haemodialysis.

Basok AB, Rogachev B, Haviv YS, Vorobiov M.

BMJ Case Rep. 2018 Jun 4;2018. pii: bcr-2017-223772. doi: 10.1136/bcr-2017-223772.

10.

Quantitative Analysis of Peptide-Matrix Interactions in Lyophilized Solids Using Photolytic Labeling.

Chen Y, Topp EM.

Mol Pharm. 2018 Jul 2;15(7):2797-2806. doi: 10.1021/acs.molpharmaceut.8b00283. Epub 2018 Jun 1.

PMID:
29792715
11.

Synergistic and non-synergistic effects of salmon calcitonin and omega - 3 fatty acids on antioxidant, anti-inflammatory, and haematological indices in diabetic rats.

Adeyemi WJ, Olayaki LA.

Biomed Pharmacother. 2018 Mar;99:867-875. doi: 10.1016/j.biopha.2018.01.085. Epub 2018 Feb 20.

PMID:
29710486
12.

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.

Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly J, Fischer MA, Kesselheim AS, Gagne JJ.

BMJ. 2018 Apr 3;361:k1180. doi: 10.1136/bmj.k1180.

14.

In Vitro-In Vivo Evaluation of an Oral Ghost Drug Delivery Device for the Delivery of Salmon Calcitonin.

Hibbins AR, Govender M, Indermun S, Kumar P, du Toit LC, Choonara YE, Pillay V.

J Pharm Sci. 2018 Jun;107(6):1605-1614. doi: 10.1016/j.xphs.2018.02.004. Epub 2018 Feb 13.

PMID:
29452142
15.

Calcitonin and Omega-3 Fatty Acids Exhibit Antagonistic and Non-Additive Effects in Experimental Diabetes.

Adeyemi WJ, Olayaki LA.

Pathophysiology. 2018 Jun;25(2):117-123. doi: 10.1016/j.pathophys.2018.02.003. Epub 2018 Feb 9.

PMID:
29449103
16.

Three-Month Randomized Clinical Trial of Nasal Calcitonin in Adults with X-linked Hypophosphatemia.

Sullivan R, Abraham A, Simpson C, Olear E, Carpenter T, Deng Y, Chen C, Insogna KL.

Calcif Tissue Int. 2018 Jun;102(6):666-670. doi: 10.1007/s00223-017-0382-0. Epub 2018 Jan 30.

17.

Salmon calcitonin ameliorates migraine pain through modulation of CGRP release and dural mast cell degranulation in rats.

Kilinc E, Dagistan Y, Kukner A, Yilmaz B, Agus S, Soyler G, Tore F.

Clin Exp Pharmacol Physiol. 2018 Jun;45(6):536-546. doi: 10.1111/1440-1681.12915. Epub 2018 Feb 13.

PMID:
29344989
18.

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study.

Lu C, Chen Y, Zhang B, Chen Y, Bai F, Chen D.

Clin Interv Aging. 2017 Oct 12;12:1717-1723. doi: 10.2147/CIA.S140900. eCollection 2017.

19.
20.

Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.

Kamgar-Parsi K, Hong L, Naito A, Brooks CL 3rd, Ramamoorthy A.

J Biol Chem. 2017 Sep 8;292(36):14963-14976. doi: 10.1074/jbc.M117.791236. Epub 2017 Jul 24.

Supplemental Content

Loading ...
Support Center